Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lotz

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Minerva Medica|November 1, 1992
[Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)]D Diacinti, G B Salabè, A Olivieri, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2015
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibitionGerald J Roth, Armin Heckel, Jörg T Kley, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2015
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part III: Discovery of pre-clinical development candidate BI 186908Thorsten Oost, Armin Heckel, Jörg T Kley, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2015
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part I: Optimization of HTS hits towards an in vivo efficacious tool compound BI 414Stephan G Müller, Armin Heckel, Jörg T Kley, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Minerva Medica|November 1, 1992
[Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)]D Diacinti, G B Salabè, A Olivieri, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2015
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibitionGerald J Roth, Armin Heckel, Jörg T Kley, et al.
Bioorganic & Medicinal Chemistry Letters|June 25, 2015
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part III: Discovery of pre-clinical development candidate BI 186908Thorsten Oost, Armin Heckel, Jörg T Kley, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2015
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part I: Optimization of HTS hits towards an in vivo efficacious tool compound BI 414Stephan G Müller, Armin Heckel, Jörg T Kley, et al.
Pageof 2